Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

54.84 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,704
Open 54.84
Bid (Size) 55.04 (200)
Ask (Size) 55.30 (200)
Prev. Close 54.84
Today's Range 54.84 - 54.84
52wk Range 54.11 - 93.25
Shares Outstanding 390,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
DexCom Inc (NASDAQ:DXCM) Embodies the Affordable Growth Investment Method
DexCom (DXCM) offers affordable growth with strong expansion, solid profitability, and a reasonable valuation in the diabetes care market. 
Via Chartmill
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via TheNewswire.com
Topics Lawsuit

Performance

YTD
-30.1%
-30.1%
1 Month
-15.9%
-15.9%
3 Month
-29.6%
-29.6%
6 Month
-35.5%
-35.5%
1 Year
-22.0%
-22.0%

More News

Read More
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Lawsuit
Lowey Dannenberg Notifies DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for Investors - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for Investors - Contact Levi & Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
DXCM REMINDER: Kessler Topaz Meltzer & Check, LLP Urges DXCM Investors with Losses to Contact the Firm
Via NewMediaWire
Topics Lawsuit
DXCM REMINDER: Kessler Topaz Meltzer & Check, LLP Urges DXCM Investors with Losses to Contact the Firm
Via TheNewswire.com
Topics Lawsuit
Class Action Announcement for DexCom, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against DexCom, Inc. - Contact Kessler Topaz Meltzer & Check, LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Class Action Announcement for DexCom, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against DexCom, Inc. - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Fraud Lawsuit
Why TAL Education, Shake Shack And DexCom Just Appeared On Value Investors' Radars
Via Benzinga
What's going on in today's session: S&P500 movers
Via Chartmill
Friday's session: top gainers and losers in the S&P500 index
Via Chartmill
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
Gapping S&P500 stocks in Friday's session
Via Chartmill
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 26, 2025 - DXCM
Via NewMediaWire
Topics Fraud Lawsuit
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 26, 2025 - DXCM
Via TheNewswire.com
Topics Fraud Lawsuit
Kaplan Fox Alerts Investors of DexCom, Inc. (DXCM) to a Securities Class Action Deadline on December 26, 2025
Via NewMediaWire
Topics Lawsuit
Kaplan Fox Alerts Investors of DexCom, Inc. (DXCM) to a Securities Class Action Deadline on December 26, 2025
Via TheNewswire.com
Topics Lawsuit
From Dividends to Growth: Why These 3 Stocks Stand Out in 2025
Via MarketBeat
Investors Who Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class Action - DXCM
Via NewMediaWire
Topics Fraud Lawsuit
Investors Who Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class Action - DXCM
Via TheNewswire.com
Topics Fraud Lawsuit
The 5 Most Interesting Analyst Questions From DexCom’s Q3 Earnings Call
Via StockStory
Topics Earnings
DXCM: Kirby McInerney LLP Advises DexCom, Inc. Investors of Class Action Lawsuit
From Kirby McInerney LLP
Via GlobeNewswire
3 Nasdaq 100 Stocks Worth Investigating
Via StockStory

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?
Yes, DexCom, Inc. - Common Stock is publicly traded.
What exchange does DexCom, Inc. - Common Stock trade on?
DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DexCom, Inc. - Common Stock?
The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market
What is the current price of DexCom, Inc. - Common Stock?
The current price of DexCom, Inc. - Common Stock is 54.84
When was DexCom, Inc. - Common Stock last traded?
The last trade of DexCom, Inc. - Common Stock was at 11/10/25 04:00 PM ET
What is the market capitalization of DexCom, Inc. - Common Stock?
The market capitalization of DexCom, Inc. - Common Stock is 21.39B
How many shares of DexCom, Inc. - Common Stock are outstanding?
DexCom, Inc. - Common Stock has 21B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.